Clinical Trial

Azithromycin for Preventing Maternal and Neonatal Infections During Labor.

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated May 6, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
In this study, we want to see the role of the antibiotic, azithromycin, in preventing maternal and neonatal infections, if the drug is given intrapartum to the mother
Trial Details
NCT Number NCT06958146
Lead Sponsor Armed Forces Hospital, Pakistan
Conditions Maternal and Neonatal Sepsis, Intrapartum Antibiotics
Enrollment 400 participants
Start Date 2025-05-01
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-06